◆ The Drug Enforcement Administration (DEA) has extended telemedicine flexibilities for controlled medicine prescriptions for six months, according to a temporary rule published in the Federal Register May 10.^[1] That means physicians can continue to prescribe controlled substances to patients by telehealth without an initial in-person visit, the same way they did during the COVID-19 public health emergency, until Nov. 11. The rule came down a day before the PHE and many of its waivers ended on May 11. Meanwhile, the DEA continues to work on a permanent rule on telehealth prescriptions for controlled substances. The March 1 proposed version elicited 38,000 comments.